NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 58 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $153,135 | -6.6% | 184,500 | -21.2% | 0.00% | – |
| Q1 2023 | $163,940 | +28.7% | 234,200 | -6.4% | 0.00% | – |
| Q4 2022 | $127,403 | -49.4% | 250,300 | -36.5% | 0.00% | -100.0% |
| Q3 2022 | $252,000 | -36.8% | 394,000 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $399,000 | -26.5% | 387,600 | +34.1% | 0.00% | 0.0% |
| Q1 2022 | $543,000 | -52.0% | 289,000 | +23.1% | 0.00% | -66.7% |
| Q4 2021 | $1,131,000 | -10.4% | 234,700 | +34.4% | 0.00% | 0.0% |
| Q3 2021 | $1,262,000 | +129.0% | 174,600 | +192.5% | 0.00% | +200.0% |
| Q2 2021 | $551,000 | -44.2% | 59,700 | -25.7% | 0.00% | -66.7% |
| Q1 2021 | $988,000 | -47.4% | 80,300 | -39.7% | 0.00% | -40.0% |
| Q4 2020 | $1,877,000 | +96.3% | 133,100 | +67.0% | 0.01% | +66.7% |
| Q3 2020 | $956,000 | +48.9% | 79,700 | +105.9% | 0.00% | +50.0% |
| Q2 2020 | $642,000 | +184.1% | 38,700 | +94.5% | 0.00% | +100.0% |
| Q1 2020 | $226,000 | -31.5% | 19,900 | -25.7% | 0.00% | 0.0% |
| Q4 2019 | $330,000 | +202.8% | 26,800 | -30.2% | 0.00% | – |
| Q3 2019 | $109,000 | – | 38,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,862,931 | $46,355,000 | 3.30% |
| Opaleye Management Inc. | 1,386,300 | $16,636,000 | 3.25% |
| Fairmount Funds Management LLC | 372,748 | $4,473,000 | 1.90% |
| Redmile Group, LLC | 4,172,686 | $50,072,000 | 0.92% |
| Boxer Capital, LLC | 1,501,058 | $18,013,000 | 0.62% |
| Prosight Management, LP | 66,376 | $797,000 | 0.38% |
| HighVista Strategies LLC | 39,234 | $471,000 | 0.34% |
| Baker Brothers Advisors | 3,821,740 | $45,861,000 | 0.18% |
| Granahan Investment Management | 296,511 | $3,558,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $460,000 | 0.09% |